These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31364081)

  • 1. Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.
    Nation RL; Forrest A
    Adv Exp Med Biol; 2019; 1145():219-249. PubMed ID: 31364081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?
    Zavascki AP; Nation RL
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Polymyxins in Animals.
    Marchand S; Grégoire N; Couet W
    Adv Exp Med Biol; 2019; 1145():89-103. PubMed ID: 31364073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin combinations: pharmacokinetics and pharmacodynamics for rationale use.
    Bergen PJ; Bulman ZP; Saju S; Bulitta JB; Landersdorfer C; Forrest A; Li J; Nation RL; Tsuji BT
    Pharmacotherapy; 2015 Jan; 35(1):34-42. PubMed ID: 25630411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalysis and Stability of Polymyxins.
    Milne RW
    Adv Exp Med Biol; 2019; 1145():73-87. PubMed ID: 31364072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?
    Bergen PJ; Landersdorfer CB; Zhang J; Zhao M; Lee HJ; Nation RL; Li J
    Diagn Microbiol Infect Dis; 2012 Nov; 74(3):213-23. PubMed ID: 22959816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin B versus colistin: an update.
    Cai Y; Lee W; Kwa AL
    Expert Rev Anti Infect Ther; 2015; 13(12):1481-97. PubMed ID: 26488563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colistin and polymyxin B: peas in a pod, or chalk and cheese?
    Nation RL; Velkov T; Li J
    Clin Infect Dis; 2014 Jul; 59(1):88-94. PubMed ID: 24700659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on the arsenal for multidrug-resistant Acinetobacter infections: polymyxin antibiotics.
    Kassamali Z; Jain R; Danziger LH
    Int J Infect Dis; 2015 Jan; 30():125-32. PubMed ID: 25461655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats.
    Sivanesan S; Roberts K; Wang J; Chea SE; Thompson PE; Li J; Nation RL; Velkov T
    J Nat Prod; 2017 Jan; 80(1):225-229. PubMed ID: 28080060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational Combinations of Polymyxins with Other Antibiotics.
    Bergen PJ; Smith NM; Bedard TB; Bulman ZP; Cha R; Tsuji BT
    Adv Exp Med Biol; 2019; 1145():251-288. PubMed ID: 31364082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Pharmacodynamics and PK/PD in Animals.
    Lee W; Cai Y; Lim TP; Teo J; Chua SC; Kwa AL
    Adv Exp Med Biol; 2019; 1145():105-116. PubMed ID: 31364074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polymyxins - review with emphasis on nephrotoxicity].
    Mendes CA; Burdmann EA
    Rev Assoc Med Bras (1992); 2009; 55(6):752-9. PubMed ID: 20191233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To B or not to B, that is the question: is it time to replace colistin with polymyxin B?
    Kassamali Z; Danziger L
    Pharmacotherapy; 2015 Jan; 35(1):17-21. PubMed ID: 25346395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus.
    Nation RL; Li J; Cars O; Couet W; Dudley MN; Kaye KS; Mouton JW; Paterson DL; Tam VH; Theuretzbacher U; Tsuji BT; Turnidge JD
    Lancet Infect Dis; 2015 Feb; 15(2):225-34. PubMed ID: 25459221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxins for the treatment of extensively-drug-resistant Gram-negative bacteria: from pharmacokinetics to bedside.
    Zavascki AP
    Expert Rev Anti Infect Ther; 2014 May; 12(5):531-3. PubMed ID: 24666285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of polymyxins: new insights into an 'old' class of antibiotics.
    Velkov T; Roberts KD; Nation RL; Thompson PE; Li J
    Future Microbiol; 2013 Jun; 8(6):711-24. PubMed ID: 23701329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing use of colistin and polymyxin B in the critically ill.
    Nation RL; Li J
    Semin Respir Crit Care Med; 2007 Dec; 28(6):604-14. PubMed ID: 18095224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human oligopeptide transporter 2 (PEPT2) mediates cellular uptake of polymyxins.
    Lu X; Chan T; Xu C; Zhu L; Zhou QT; Roberts KD; Chan HK; Li J; Zhou F
    J Antimicrob Chemother; 2016 Feb; 71(2):403-12. PubMed ID: 26494147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.